The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2 - Evaluation of the accuracy and ease-of-use [Research Data]
收藏heiDATA2021-04-30 更新2026-05-11 收录
下载链接：
https://heidata.uni-heidelberg.de/citation?persistentId=doi:10.11588/DATA/FSPQL4
下载链接
链接失效反馈官方服务：
资源简介：
This repository includes data from a prospective, multi-centre diagnostic accuracy study. The study was conducted at two sites in Germany, Heidelberg and Berlin. Following routine testing with reverse-transcriptase polymerase chain reaction (RT-PCR), a second study-exclusive swab was performed for Ag-RDT testing. Routine swabs were nasopharyngeal (NP) or combined NP/oropharyngeal (OP) whereas the study-exclusive swabs were NP. To evaluate performance, sensitivity and specificity were assessed overall and in predefined sub analyses accordingly to cycle-threshold values, days of symptoms, disease severity and study site. In addition, further data from the participants were collected during interviews.
提供机构：
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Medical Directorate; Virology, Heidelberg University Hospital; Division of Clinical Tropical Medicine, Heidelberg University Hospital, Heidelberg; Department of Public Health Rhein Neckar Region; Foundation for Innovative New Diagnostics; Division of Clinical Tropical Medicine, Department of Infectious Diseases, University of Heidelberg, Heidelberg, Germany; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institute of Tropical Medicine and International Health; Department of Laboratory Medicine, Boston Children’s Hospital; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institute of Virology
创建时间：
2020-09-28
